Endocrine-related adverse events following ipilimumab in patients with advanced melanoma: a comprehensive retrospective review from a single institution
M Ryder, M Callahan, MA Postow… - Endocrine-related …, 2014 - erc.bioscientifica.com
Novel immune checkpoint blockade with ipilimumab, an antibody blocking the cytotoxic T-
lymphocyte antigen 4 (CTLA4), is revolutionizing cancer therapy. However, ipilimumab …
lymphocyte antigen 4 (CTLA4), is revolutionizing cancer therapy. However, ipilimumab …
Endometrial cancer in Lynch syndrome
S Zhao, L Chen, Y Zang, W Liu, S Liu… - … Journal of Cancer, 2022 - Wiley Online Library
Lynch syndrome (LS) is an autosomal dominant inherited disease caused by germline
pathogenic variants (PVs) in mismatch repair (MMR) genes. LS‐associated endometrial …
pathogenic variants (PVs) in mismatch repair (MMR) genes. LS‐associated endometrial …
Sex disparities in cancer mortality and survival
MB Cook, KA McGlynn, SS Devesa… - … , biomarkers & prevention, 2011 - AACR
Background: Previous research has noted higher cancer mortality rates and lower survival
among males than females. However, systematic comparisons of these two metrics by sex …
among males than females. However, systematic comparisons of these two metrics by sex …
Estrogen receptors and their implications in colorectal carcinogenesis
Upon binding their cognate receptors, ERα (ESR1) and ERβ (ESR2), estrogens activate
intracellular signaling cascades that have important consequences for cellular behavior …
intracellular signaling cascades that have important consequences for cellular behavior …
Development of subtype-selective oestrogen receptor-based therapeutics
S Nilsson, KF Koehler, JÅ Gustafsson - Nature reviews Drug discovery, 2011 - nature.com
The two oestrogen receptor subtypes α and β are hormone-regulated modulators of
intracellular signalling and gene expression. Regulation of oestrogen receptor activity is …
intracellular signalling and gene expression. Regulation of oestrogen receptor activity is …
Estrogen receptor beta as target for colorectal cancer prevention
Colorectal cancer (CRC) is a leading cause of death in the United States. Despite its slow
development and the capacity for early diagnosis, current preventive approaches are not …
development and the capacity for early diagnosis, current preventive approaches are not …
Polymyositis/dermatomyositis and malignancy risk: a metaanalysis study
Z Yang, F Lin, B Qin, Y Liang, R Zhong - The Journal of rheumatology, 2015 - jrheum.org
Objective. To investigate the association between polymyositis (PM)/dermatomyositis (DM)
and risks of malignancy. Methods. We searched Pubmed for articles dated before August 16 …
and risks of malignancy. Methods. We searched Pubmed for articles dated before August 16 …
Tumor repressive functions of estrogen receptor β in SW480 colon cancer cells
J Hartman, K Edvardsson, K Lindberg, C Zhao… - Cancer research, 2009 - AACR
Estrogen receptor β (ERβ) is the predominant ER in the colorectal epithelium. Compared
with normal colon tissue, ERβ expression is reduced in colorectal cancer. Our hypothesis is …
with normal colon tissue, ERβ expression is reduced in colorectal cancer. Our hypothesis is …
The G Protein-Coupled Estrogen Receptor (GPER): a critical therapeutic target for cancer
KA Hall, EJ Filardo - Cells, 2023 - mdpi.com
Estrogens have been implicated in the pathogenesis of various cancers, with increasing
concern regarding the overall rising incidence of disease and exposure to environmental …
concern regarding the overall rising incidence of disease and exposure to environmental …
[HTML][HTML] 5-Fluorouracil in Combination with Calcium Carbonate Nanoparticles Loaded with Antioxidant Thymoquinone against Colon Cancer: Synergistically …
Colon cancer is the third most common cancer worldwide, with high mortality. Adverse side
effects and chemoresistance of the first-line chemotherapy 5-fluorouracil (5-FU) have …
effects and chemoresistance of the first-line chemotherapy 5-fluorouracil (5-FU) have …